Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Palisade Bio Inc
(NQ:
PALI
)
2.460
+0.040 (+1.65%)
Streaming Delayed Price
Updated: 1:00 PM EST, Nov 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Palisade Bio Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
12 Health Care Stocks Moving In Friday's After-Market Session
December 23, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 20, 2022
On Tuesday, 298 companies achieved new lows for the year.
Via
Benzinga
Palisade Bio Voluntarily Ceases Enrollment In Its Lead Program Study
December 16, 2022
Via
Benzinga
Why Is Palisade Bio (PALI) Stock Up 130% Today?
November 22, 2022
Today's rally in PALI stock appears to be tied directly to an FDA announcement that it's fast tracking a key drug from the company.
Via
InvestorPlace
Peering Into Palisade Bio's Recent Short Interest
December 12, 2022
Palisade Bio's (NASDAQ:PALI) short percent of float has risen 14313.64% since its last report. The company recently reported that it has 428 thousand shares sold short, which is 31.71% of all regular...
Via
Benzinga
Palisade Bio Announces Early Exercise of Warrants Resulting in Cash Proceeds of $1.25 Million
December 07, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Palisade Bio Regains Compliance with Nasdaq Listing Requirements
December 01, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
November 23, 2022
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 58.4% to $0.1069 in pre-market trading after gaining more than 16% on Tuesday.
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
November 21, 2022
Via
Benzinga
Palisade Bio Streamlines Operations To Focus Lead Clinical Program
September 15, 2022
Via
Benzinga
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
November 23, 2022
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on...
Via
Benzinga
Dow Jumps Over 300 Points; S&P 500 Rises 1%
November 22, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Tuesday.
Via
Benzinga
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
November 22, 2022
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel...
Via
Benzinga
Palisade Bio (NASDAQ: PALI) Awarded Fast Track Designation from U.S. FDA for LB1148
November 22, 2022
Palisade Bio, Inc. (NASDAQ: PALI) is engaged as a biopharmaceutical company, which is focused on the research and development of
Via
Spotlight Growth
Exposures
Product Safety
Crude Oil Surges 2%; Best Buy Posts Upbeat Earnings
November 22, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 250 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 22, 2022
Via
Benzinga
US Stocks Open Higher As Dow Surges 250 Points
November 22, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Tuesday.
Via
Benzinga
Palisade Bio is Granted Fast Track Designation from the U.S. Food and Drug Administration for LB1148 for Accelerated Return of Bowel Function following GI Surgery
November 22, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Palisade Bio Appoints Herbert B. Slade, MD, FAAAAI as Chief Medical Officer
November 18, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Palisade Bio Releases In-Depth Explanation of Scientific Approach of Lead Product Candidate LB1148 Through Animated Video
November 17, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
November 16, 2022
Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday.
Via
Benzinga
Palisade Bio Announces Reverse Stock Split
November 15, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Palisade Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Palisade Bio Announces Executive Leadership Transition
October 11, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 05, 2022
It's time for another overview of the biggest pre-market stock movers for Wednesday as we cover the news behind share movement this morning!
Via
InvestorPlace
Why Vicinity Motor Is Trading Higher By Over 65%; Here Are 26 Stocks Moving Premarket
October 05, 2022
Gainers Vicinity Motor Corp. (NASDAQ: VEV) rose 65.4% to $1.72 in pre-market trading. Vicinity Motor started deliveries of the first Class 3 electric truck to roll off the assembly line in Canada.
Via
Benzinga
Palisade Bio Announces Oral Presentation of Phase 2 Data at the American College of Surgeons (ACS) Clinical Congress 2022
September 29, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
September 14, 2022
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022
August 19, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 18, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.